Industries
SPIL
Members
Secretary
Pharmaceutical executive with more than 30 years of experience spanning industry leadership, quality systems, and organizational development. As Chairman & General Manager of Mephico S.A.L., Lebanon’s first national pharmaceutical manufacturer, I oversee the company’s strategic direction, modernization initiatives, and expansion of its product portfolio. Under my leadership, Mephico continues to strengthen its reputation for excellence in GMP compliance, product quality, and contribution to national healthcare resilience.
Previously, I spent 15 years as a management and organizational consultant, advising more than 150 companies across Europe, the Middle East, Africa in diverse sectors including pharmaceuticals, healthcare, telecom, and industrial manufacturing on ISO standards, risk management, and performance optimization, while developing expertise in leading multicultural teams and managing complex change.
My academic foundation combines a Pharm.D. with a specialization in Industrial Pharmacy and a Diploma of Specialized Studies in Quality Assurance (Paris V). I also hold an MBA in Finance & Accounting (LAU) and pursued professional training in Mediation and Alternative Dispute Resolution (Saint Joseph University, Beirut), equipping me with both the technical and interpersonal skills to lead organizations through transformation and growth.
I remain passionate about advancing pharmaceutical innovation, ensuring access to high-quality medicines, and fostering collaboration across industries and cultures to strengthen healthcare systems.
Board member
Experienced entrepreneur and Board member of major pharmaceuticals, medical equipment and devices’ companies dealing with manufacturing and distribution in the MENA region.
Serum and Solutions S.A.L. is a producer of Large Volume Parenterals (LVP) solutions, meeting the following quality requirements:
Located in Lebanon, Baalbek, Sarhine , Dr Mohamad Abdallah street – P.O box # 3 .On a clean spot of 30,000 square meters away enough from any eventual pollution. The plant is also designed as a green plant reliable on a solar energy in order to promote a sustainable development.
The fundamental purpose and corporate culture of S&S is to provide our healthcare customers with the safest and most efficient large volume parenteral.
S&S management strategy will be articulated around 5 main objectives:
Founded in 2009 by Mr. Abdul Razzaq Yousef as founder and Dr. Ruwayda Dham as co-founder, ARWAN Pharmaceutical Industries Lebanon s.a.l. is a joint stock company owned by a group of Lebanese and non Lebanese highly committed professionals. The company commenced operations in 2013 with its first sterile injectables manufacturing unit, comprising Phase I of the project with other phases to come in the near future.
ARWAN develops, manufactures and markets critical care products, focusing on new generations anti-infectives, hematinics, anesthetics and analgesics, gastrointestinals, oncology, antiasthmatics, cardiovasculars, osteoporosis and wound management modalities.
To bridge time gaps and expedite our presence in the market, ARWAN collaborates with leading European companies in contract manufacturing, producing for ARWAN value-added anti-infectives, anesthetics, cardiovasculars, antipsychotics and antiasthmatics where EMEA and/or USA FDA approved facilities and operations reinforce further ARWAN’s quest for quality.
Privileged by its presence in Lebanon, the heart of the MENA and the hub of expert healthcare professionals and high-reputation hospitals and medical centers, ARWAN paved its way towards leadership in providing high-end critical care products not only in Lebanon, but also in neighboring countries where fast-track trust is influenced by the local professional experience.
ARWAN markets extend beyond Lebanon to cover the 20 countries of MENA as well as Africa where the large Lebanese diaspora acts as a liaison in establishing businesses and forging partnership.
Committed to quality in providing cost-effective critical care products,
ARWAN will always Assure Reliability When Absolutely Needed, whether by patients or healthcare institutions.
UBSA Pharma Industries’ manufacturing facility, situated as the first pharmaceutical establishment in northern Lebanon, features an exceptionally proficient and motivated workforce. Our team is highly skilled and deeply committed to ensuring your well-being, prioritizing your health and safety, and providing you with high-quality products.
The inspiration for our company arose in the wake of the COVID-19 pandemic and the severe economic crisis that Lebanon endured. These challenging times led to a significant shortage of essential medicines and infant formula, highlighting the urgent need for a reliable local pharmaceutical supply.
Motivated by this crisis, we were driven to invest in the local pharmaceutical industry, with the goal of providing continuous and dependable access to high-quality pharmaceutical products and infant formula for the Lebanese market and the surrounding region.
We received our initial operating permit on February 1st, 2021. After three years of unwavering hard work, commitment, dedication and with the invaluable assistance of top experts and consultants from multiple countries, we successfully obtained GMP certification and ISO 14001, ISO 9001, ISO 45001.
Our state-of-the-art facility leverages the latest technology to ensure the production of top-quality pharmaceutical products at competitive prices. We prioritize your health and safety above all, ensuring that we consistently deliver excellence in every aspect of our operations. Our highly skilled and motivated team is deeply committed to contributing to the development of the pharmaceutical industry in Lebanon.
Dynamic and growing, MEDIPHAR Laboratories is a pharmaceutical company involved in developing, manufacturing and marketing of generic and branded products in Lebanon and other regional markets.
Established in 1973 by Mr. Habib Edmond Fadel, the founder made commitments to himself and to the society to develop pharmaceutical products of highest possible quality with a motivated and qualified team conscious of their mission with respect to current Good Manufacturing Practices (cGMP).
We maintain a diverse product portfolio which covers major therapeutic areas including Alimentary Tract & Metabolism, Cardiovascular System, Dermatological, Genito-Urinary System & Sex Hormones, Systemic Hormonal Preparations, General Anti-Infectives, Musculo-Skeletal System, Central Nervous System and Respiratory System, Vitamins & supplements.
MEDIPHAR Laboratories continues its development of strategies to maintain its preeminent position of excellence and to continue to deliver the finest affordable products, both multi-source and branded, to healthcare professionals.
Our Mission is to always deliver a wide range of high quality drugs that meet international standards, patients’ needs and healthcare professionals’ expectations.
Our Vision is to be a leading pharmaceutical company by discovering and developing innovative, value-added medicines that improve the quality of life for patients.
MEDIPHAR stands for quality, trust and reliability.
MEPHICO S.A.L. – Middle East Pharmaceutical & Industrial Company – the first national pharmaceutical manufacturing company was established in 1956 by a group of prominent pharmacists.
In 1962 it moved from Beirut to its newly built high production capacity plant in Jamhour.
In 1965, in addition to its own line of products, MEPHICO started manufacturing under licence for leading international pharmaceutical companies.
Presently MEPHICO S.A.L. is firmly established as one of the most considered Lebanese pharmaceutical firms with a reputation of distinction in quality and reliability of its products.
In renovation of its plant, two additional floors that have been added to its building, are actually on the way to be equipped with all new installations and equipment in conformance with the current Good Manufacturing standard. This will lead to increase the production capacity and the possibilities to launch new products for the benefit of local pharmaceutical industry.
Needless to mention that our main objective is to ensure the best pharmaceutical product to the largest number of patients and to develop new products that will help maintain the health care process at its highest level of excellence.
At Pharmaline, our highly skilled talent is committed to increasing access to healthcare by providing quality medicines & excellence in service. Since our establishment in 1987, we have produced medicines that are in line with current Good Manufacturing Practice (cGMP). Our manufacturing plant built according to EU norms and holding ISO 1400:2004 is among the most reputable in the region, allowing us to be the trusted licensee for several of the world’s most established multinationals such as Abbott, Delorbis, GSK, Merck Serono, Novartis, Phadisco, Pierre Fabre, Sandoz, and Tripharma, covering Lebanon and the region. Pharmaline is present in the Levant, GCC Arabian Gulf, Africa, and Europe. Locally, we are expanding our manufacturing capabilities to constantly supply a growing market. On a regional level, Pharmaline continues to extend its pharmaceutical footprint, which is to include a new manufacturing facility in King Abdallah Economic City in Saudi Arabia.
Pharma M is a Lebanese pharmaceutical manufacturing company working under GMP. Pharma M is one of the few companies in the Middle East specializing in the production of dietary supplements. All the products are made using the best sources of raw material and the most studied ingredients. Pharma M products are unique in their formulations which are based on the latest studies, and have the most effective compositions on the market.
Founded in 1970, PHARMADEX s.a.l. is one of Lebanon’s leading manufacturer of pharmaceutical products with a management systems registered to ISO 9001:2008.
The plant is engaged in the production of a wide variety of pharmaceutical products such as tablets, capsules, solutions and suspensions, creams, ointments, suppositories, etc. according to the Good Manufacturing Practices (GMPs) rules.
Our aim is to produce high quality medicines that meet the international standards.
Benta Pharma Industries (BPI) is a leader in the pharmaceutical industry committed to manufacturing high quality pharmaceutical products as well as medical devices, thus improving human health and well being.
BPI has become a front runner in manufacturing enhanced formulations for the treatment of a wide range of central nervous system and cardiovascular diseases, dyslipidemia, diabetes, urology, dermatology, anesthesia, transplant, infection, and hematology. BPI also produces oncology, biotech and sterile products.
BPI manufactures high-quality sterile medical devices designed for a wide range of hospital uses such as anesthesia, urology, surgery, cardiovascular and IV administration.
BPI has earned a number of International, regional, and local certificates. The most important of these are the European Good Manufacturing Practice (GMP) and ISO 9001: 2008. Our medical devices also meet the highest standards of the European Union and have acquired the CE marking.
BPI has also signed in license and out license agreements with notable multinational companies such as Abbott, CSL Behring, Mylan, Sanofi, Zentiva and Actavis.
BPI is expanding strategically, with already a diversified presence including industrial operations and scientific offices in over 30 countries like the Gulf, Egypt, Iraq, France, Russia and Africa.
ALGORITHM pharmaceutical manufacturers based in Lebanon, is the trusted regional partner to medical and patient communities and is committed to delivering quality care in pharmaceutical therapies. It operates in The Middle East and North Africa regions with a product portfolio consisting of innovative products under license from international companies, as well as differentiated generics, focusing mainly on the following therapeutic areas: cardiology, endocrinology, neurology, gynecology and urology.
Our ultimate aim is the human well-being by providing quality products to the health care professionals, developed by a dedicated and committed team of highly skilled personnel.
ALGORITHM has built its legacy and reputation around a few core values; those same values will drive the Company to shape its future.
Trust and Respect, Ethics and Integrity, Responsibility and Accountability, Quality and Excellence are the core values that will guide us in all that we do; they serve as the foundation in our efforts to carry out the vision of the Company and are to be applied through codes of conduct with each of our key stakeholders.
Since the early 70s, and with the technical assistance of Laboratoires Aguettant, Serum Products has been manufacturing and marketing small and large parenteral solutions and irrigation solutions for hospital use. The Company has a strong presence in the Lebanese healthcare market and the Levant region.
SERUM PRODUCTS facilities are equipped with modernized and automated machinery complying with the latest international pharmaceutical industry requirements. We are highly sensitive to quality and strictly adhere to GMP principles.
SERUM PRODUCTS has put in place a solid quality assurance system in compliance with GMP requirements and ISO 9001: 2008 standards to ensure consistency of the product quality and patient safety.
SERUM PRODUCTS system is continuously monitored and controlled by highly qualified and trained personnel throughout the whole product lifecycle from selection and reception of raw materials to manufacturing and distribution of our products. All our processes are validated and our equipment is qualified to ensure safe and reliable products.
Our quality control laboratories are supplied with the latest sophisticated instruments to perform stringent quality control analysis complying with international standards and to guarantee the quality of our products as per the latest requirements of US pharmacopeia.
We are always aiming for the continual improvement of our activity and the permanent satisfaction of our customers.
CHAPHA s.a.l was established in 1964 and became a member of PharmaGroup Holding in 2017.
CHAOUL Pharmaceuticals (CHA-PHA) is cGMP certified by the Lebanese Ministry of Public Health and is licensed to produce and pack branded generic products, as well as products under license from leading European companies based in France, Italy, Spain, and Switzerland, in various pharmaceutical forms: oral solid dosage, oral liquid dosage, semi-solid dosage, topical liquid dosage, and suppositories.
For over 60 years, CHAPHA has remained dedicated to manufacturing medicines that meet the highest quality standards and offer the most competitive prices, driven by a mission to help as many patients as possible. And, despite the significant challenges facing Lebanon’s pharmaceutical industry, CHAPHA remains resilient, driven by innovation and a commitment to the highest quality standards, offering promising opportunities for growth.
The team brings together extensive experience and a renewed ambition to innovate and evolve, ensuring that the patient’s best interest remains at the heart of every decision.
Our advanced laboratory, featuring equipment from Europe and the USA, supports our rigorous quality assurance system, guaranteeing the safety, efficacy, and compliance of every product we deliver.
CHAPHA is also committed to environmental sustainability and minimizing ecological footprint.
Contributing to the advancement of the pharmaceutical industry is both a challenge and a privilege, and CHAPHA is proud to be among those shaping its future day after day.
CHAPHA, Patient-Centric Solutions.
Established in 1973 under the technical collaboration from cutter laboratories Inc. U.S to manufacture intra venous solutions.
From automatic liquid packaging machines then, to state of the art printing and filling machines provided from Baxter labs.
Presently employing over 170 people and with an installed capacity to produce 50.000 I.V bags daily.
ALFA is today the largest Lebanese I.V solutions manufacturer, hemodialysis solutions producer, premix hemodialysis powders and sodium bicarbonate cartridges.
Medical devices are produced in a class C clean room built by Plasteurope France.
ALFA has diversified to fill glass ampoules, oral rehydration solutions, nasal sprays and disinfectants.
Currently exporting to some Middle Eastern and African countries.
cGMP norms are being finalized and by the first quarter of 2016 we should be fully compliant with all the Lebanese M.O.P.H norms.
Currently exporting to some Middle Eastern and African countries.
cGMP norms are being finalized and by the first quarter of 2016 we should be fully compliant with all the Lebanese M.O.P.H norms.
Board member
Tarek Tabbara is a Partner and CEO/General Manager of Serum Products s.a.l., a leading pharma company manufacturing parenteral solutions, operating in Lebanon and the Levant. He holds a Master’s in Industrial Management (USJ) and an MBA (ESA). With over 27 years of experience, he has held executive roles across pharmaceutical manufacturing, international trade, and strategic planning. He is also a board member and managing partner in several regional medical trading companies, including Solupharm s.a.l (Lebanon) and Verdalia Trading Ltd (Cyprus). Since 2016, he has served as Board Member and Treasurer of the Syndicate of Pharmaceutical Industries in Lebanon, re-elected for multiple terms.
Treasurer
Tarek Tabbara is a Partner and CEO/General Manager of Serum Products s.a.l., a leading pharma company manufacturing parenteral solutions, operating in Lebanon and the Levant. He holds a Master’s in Industrial Management (USJ) and an MBA (ESA). With over 27 years of experience, he has held executive roles across pharmaceutical manufacturing, international trade, and strategic planning. He is also a board member and managing partner in several regional medical trading companies, including Solupharm s.a.l (Lebanon) and Verdalia Trading Ltd (Cyprus). Since 2016, he has served as Board Member and Treasurer of the Syndicate of Pharmaceutical Industries in Lebanon, re-elected for multiple terms.
Vice President
Dr. Bertha Abou Zeid: Dr. in Pharmacy with over 30 years of experience in Regulatory Affairs
(RA) Pharmacovigilance and Quality. She currently serves as the Quality Unit and Regulatory
Affairs Director at Benta Group, a leading pharmaceutical company, where she plays a pivotal
role in ensuring compliance with international regulations and promoting the safety and quality
of pharmaceutical products across global markets.
Throughout her distinguished career, Dr. Abou Zeid has demonstrated a steadfast commitment
to advancing healthcare standards and regulatory excellence. Her extensive knowledge and
strategic leadership have significantly contributed to the growth and credibility of the
pharmaceutical industry in the region.
Beyond her corporate responsibilities, Dr. Abou Zeid is actively involved in shaping the future of
the pharmaceutical sector through influential leadership roles. She is the Vice President of the
Syndicate of Lebanese Pharmaceutical Industries and the President of the Syndicate of Vitamins
and Food Supplements. In these capacities, she champions public health initiatives, supports
industry innovation, and advocates for robust regulatory frameworks.
President
Dr. Abi Karam began her career at Malia Group as a Regulatory Affairs Manager. Prior to assuming her current position as the General Manager of the Company, she oversaw the industry’s functions: product development, manufacturing, quality assurance, supply chain business development, promotion, marketing, local and export sales.
During her tenure as General Manager, Dr. Abi Karam was exposed to both manufacturing activities and the corporate environment. She led Pharmaline’s significant regional development, while enhancing and consolidating its position as a leading manufacturing company in the Lebanese market, together with the company’s attainment of the EcoVadis Bronze badge and the European Good Manufacturing Practices (EU GMP) certification. She secured a large portfolio, closed license agreements and distribution deals with leading multinationals, and developed and retained a professional, motivated team.
Guided by Malia Group governance and engagement principles, she actively contributes to engaging Pharmaline in performance improvement on Environment, Social, and Governance (ESG) matters and incorporates ESG issues into the company’s policies and practices, demonstrating the company’s commitment to functioning sustainably.
She is a founding member and the incumbent President of the Syndicate of Pharmaceutical Industries in Lebanon (SPIL) established in 2016. She led the industry sector, developed and promoted its capabilities, quality, and advocacy for its role as a major pillar in both Health and the Economic Sector. She actively contributed to the development of laws and strategies regulating Health and Industry.
She is also a Board Member of the Arab Union of Pharmaceutical Manufacturers.
Dr. Abi Karam holds a Doctorate in Pharmacy from the Saint Joseph University in Lebanon.
